carprofen has been researched along with Liver Cirrhosis in 1 studies
carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
" The pharmacokinetic parameters and urinary excretion data did not differ significantly (P greater than 0." | 2.66 | The influence of liver dysfunction on the pharmacokinetics of carprofen. ( Brazzell, RK; Chen, SS; Holazo, AA; Konikoff, JJ; McMahon, FG; Ryan, JR, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holazo, AA | 1 |
Chen, SS | 1 |
McMahon, FG | 1 |
Ryan, JR | 1 |
Konikoff, JJ | 1 |
Brazzell, RK | 1 |
1 trial available for carprofen and Liver Cirrhosis
Article | Year |
---|---|
The influence of liver dysfunction on the pharmacokinetics of carprofen.
Topics: Adult; Anti-Inflammatory Agents; Carbazoles; Clinical Trials as Topic; Female; Half-Life; Hepatitis; | 1985 |